Tenofovir During Pregnancy - Does it Affect Fetal Growth?

Researchers used regression models to look for incidence of low birth weight (LBW), small for gestational age (SGA) births, and other size measures in infants born to women who used HAART regimen containing tenofovir during pregnancy. There was no significant association between tenofovir and LBW or SGA, however researchers caution that further studies of growth outcomes are warranted.

Citation:
Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, Rich KC, Griner R, Tassiopoulos K, Kacanek D, Mofenson LM, Miller T, DiMeglio LA, Watts DH; Pediatric HIV/AIDS Cohort Study (PHACS). Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed but uninfected infants. AIDS. 2012 Jun 1; 26(9):1151-9.

Original Article (subscription may be required)

Abstract